Analysis of cleavage site mutations between the NC and PR Gag domains of rous sarcoma virus

Journal of Virology

Volumn 71, Issue 1, 1997, Pages 444-450

  Schatz, Gisela ^a   Pichova, Iva ^b   Vogt, Volker M ^a  

^a Department of Obstetrics Gynecology   (United States)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GAG PROTEIN; ISOLEUCINE; MUTANT PROTEIN; POLYPEPTIDE; PROLINE; PROTEINASE; SYNTHETIC PEPTIDE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; AVIAN SARCOMA VIRUS; CONTROLLED STUDY; IMMUNOPRECIPITATION; LEUKEMIA VIRUS; MONKEY; MUTATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; QUAIL; ROUS SARCOMA ONCOVIRUS; VIRUS PARTICLE;

EID: 0031060496     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.1.444-450.1997     Document Type: Article

References (40)

1. Arad, G., R. Bar-Meir, N. Almog, M. Chorev, and M. Kotler. 1995. Avian sarcoma leukemia virus protease linked to the adjacent Gag polyprotein is enzymatically active. Virology 214:439-444.
2. 1a.Babé, L. M., J. Rosé, and C. S. Craik. 1992. Synthetic "interface" peptides alter dimeric assembly of the HIV-1 and 2 proteases. Protein Sci. 1:1244-1253.
3. Burstein, H., D. Bizub, and A. M. Skalka. 1991. Assembly and processing of avian retroviral Gag polyproteins containing linked protease dimers. J. Virol. 65:6165-6172.
4. Burstein, H., D. Bizub, M. Kotler, G. Schatz, V. M. Vogt, and A. M. Skalka. 1992. Processing of avian retroviral Gag polyprotein precursors is blocked by a mutation in the NC-PR cleavage site. J. Virol. 66:1781-1785.
5. Cameron, C. E., B. Grinde, P. Jacques, J. Jentoft, J. Leis, A. Wlodawer, and I. T. Weber. 1993. Comparison of the substrate binding pockets of Rous sarcoma virus and human immunodeficiency virus type 1 proteinases. J. Biol. Chem. 268:11711-11720.
6. Co, E., G. Koelsch, Y. Lin, E. Ido, J. A. Hartsuck, and J. Tang. 1994. Proteolytic processing mechanisms of a miniprecursor of the aspartic protease of human immunodeficiency virus type 1. Biochemistry 33:1248-1254.
7. Davies, D. R. 1990. The structure and function of the aspartic proteinases. Annu. Rev. Biophys. Chem. 19:189-215.
8. Grinde, B., C. E. Cameron, J. Leis, I. T. Weber, A. Wlodawer, H. Burstein, and A. M. Skalka. 1992. Analysis of substrate interactions of the Rous sarcoma virus wild-type and mutant proteases and human immunodeficiency virus 1 protease using a set of systematically altered peptide substrates. J. Biol. Chem. 267:9491-9498.
9. 7a.Hrusková, O. Personal communication.
10. Jaskólski, M., M. Miller, J. K. M. Rao, J. Leis, and A. Wlodawer. 1990. Structure of the aspartic protease from Rous sarcoma retrovirus refined at 1 A resolution. Biochemistry 29:5889-5898.
11. Johnson, S. P., M. Veigl, T. Vanaman, and J. Leis. 1983. Cyanogen bromide digestion of the avian myeloblastosis virus pp19 protein: isolation of an amino-terminal peptide that binds to viral RNA. J. Virol. 45:876-881.
12. Jupp, R. A., L. H. Phylip, J. S. Mills, S. F. J. LeGrice, and J. Kay. 1991. Mutating P2 and P1 residues at cleavage junctions in the HIV-1 pol polyprotein. FEBS Lett. 283:180-184.
13. Konvalinka, J. I. Blaha, R. Skrabana, J. Sedlacek, I. Pichova, F. Kapralek, V. Kostka, and P. Strop. 1991. Subsite specificity of the proteinase from myeloblastosis associated virus. FEBS Lett. 282:73-76.
14. Kotler, M., R. A. Katz, and A. M. Skalka. 1988. Activity of avian retroviral protease expressed in Eshcrichia coli. J. Virol. 62:2696-2700.
15. Kotler, M., R. A. Katz, W. Danho, J. Leis, and A. M. Skalka. 1988. Synthetic peptides as substrates and inhibitors of a retroviral PR. Proc. Natl. Acad. Sci. USA 85:4185-4189.
16. Kotler, M., W. Danho, R. A. Katz, J. Leis, and A. M. Skalka. 1989. Avian retroviral protease and cellular aspartic proteases are distinguished by activities on peptide substrates. J. Biol. Chem. 264:3428-3435.
17. Kräusslich, H.-G. 1991. Human immunodeficiency virus proteinase dimer as a component of the viral polyprotein prevents particle assembly and viral infectivity. Proc. Natl. Acad. Sci. USA 88:3213-3217.
18. Louis, J. M., N. T. Nashed, K. D. Parris, A. R. Kimmel, and D. M. Jerina. 1994. Kinetics and mechanism of autoprocessing of human immunodeficiency virus type 1 protease from an analog of the Gag-Pol polyprotein. Proc. Natl. Acad. Sci. USA 91:7970-7974.
19. Oertle, S., and P.-F. Spahr. 1990. Role of the Gag polyprotein precursor in packaging and maturation of Rous sarcoma virus genomic RNA. J. Virol. 64:5757-5763.
20. Pepinsky, R. B., I. A. Papayannopoulos, S. Campbell, and V. M. Vogt. 1996. Analysis of Rous sarcoma virus Gag proteins by mass spectrometry indicates trimming by host exopeptidase. J. Virol. 70:3313-3318.
21. Pepinsky, R. B., I. A. Papayannopoulos, E. P. Chow, N. K. Krishna, R. C. Craven, and V. M. Vogt. 1995. Differential proteolytic processing leads to multiple forms of the CA protein in avian sarcoma and leukemia viruses. J. Virol. 69:6430-6438.
22. Pettit, S. C., J. Simsic, D. D. Loeb, L. Everitt, C. A. Hutchison III, and R. Swanstrom. 1991. Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid. J. Biol. Chem. 266:14539-14547.
23. Phylip, L. H., A. D. Richards, J. Kay, J. Konvalinka, P. Strop, I. Blaha, J. Velek, V. Kostka, A. R. Ritchie, A. V. Broadhurst, W. G. Farmerie, P. E. Scarborough, and B. M. Dunn. 1990. Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinases. Biochem. Biophys. Res. Commun. 171:439-444.
24. Pichova, I., P. Strop, J. Sedlacek, F. Kapralek, V. Benes, M. Travnicek, L. Pavlickova, M. Soujcek, V. Kostka, and S. Foundling. 1992. Isolation and biochemical characterization and crystallization of the p15Gag proteinase of myeloblastosis associated virus expressed in E. coli. Int. J. Biochem. 24:235-242.
25. Poorman, R. A., A. G. Tomasselli, R. L. Heinrikson, and F. J. Kézdy. 1991. A cumulative specificity model for proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data base. J. Biol. Chem. 266:14554-14561.
26. 23a.Putterman, D., G. Schatz, and V. Vogt. Unpublished observations.
27. Richards, A. D., L. H. Phylip, W. G. Farmeries, P. E. Scarborough, A. Alvarez, B. N. Dunn, P.-H. Hirel, J. Konvalinka, P. Strop, L. Pavlickova, V. Kostka, and J. Kay. 1990. Sensitive soluble chromogenic substrates for HIV-1 proteinase. J. Biol. Chem. 265:7733-7736.
28. Ridky, T. W., C. E. Cameron, J. Leis, T. Copeland, A. Wlodawer, I. T. Weber, and R. W. Harrison. 1996. Human immunodeficiency virus, type I protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites. J. Biol. Chem. 271:4709-4717.
29. Rosé, J. R., R. Salto, and C. S. Craik. 1993. Regulation of autoproteolysis of the HIV-1 and HIV-2 proteases with engineered amino acid substitutions. J. Biol. Chem. 268:11939-11945.
30. Sakalian, M., J. W. Wills, and V. M. Vogt. 1994. Efficiency and selectivity of RNA packaging by Rous sarcoma virus gag deletion mutants. J. Virol. 68:5969-5981.
31. Séllos-Moura, M., and V. M. Vogt. 1996. Proteolytic activity of the NC-PR fragment of avian sarcoma and leukemia virus Gag protein expressed in E. coli. Virology 221:335-345.
32. Stewart, L., G. Schatz, and V. M. Vogt. 1990. Properties of avian retrovirus particles defective in viral protease. J. Virol. 64:5076-5092.
33. Stewart, L., and V. M. Vogt. 1991. trans-acting viral protease is necessary and sufficient for activation of avian leukosis virus reverse transcriptase. J. Virol. 65:6218-6231.
34. Stewart, L., and V. M. Vogt. 1993. Reverse transcriptase and protease activities of avian leukosis virus Gag-Pol fusion proteins expressed in insect cells. J. Virol. 67:7582-7596.
35. Stewart, L., and V. M. Vogt. 1994. Proteolytic cleavage at the Gag-Pol junction in avian leukosis viruses: differences in vitro and in vivo. Virology 204:45-59.
36. Vogt, V. M., R. Eisenman, and H. Diggelmann. 1975. Generation of avian myeloblastosis virus structural proteins by proteolytic cleavage of a precursor polypeptide. J. Mol. Biol. 96:471-493.
37. Wlodawer, A., and J. W. Erickson. 1993. Structure-based inhibitors of HIV-1 protease. Annu. Rev. Biochem. 62:543-585.
38. Zhang, Z. Y., R. A. Poorman, L. L. Maggiora, R. L. Heinrikson, and F. J. Kezdy. 1991. Dissociative inhibition of dimeric enzymes: kinetic characterization of the inhibition of HIV-1 protease by its carboxyl terminal tetrapeptide. J. Biol. Chem. 266:15591-15594.
39. Zybarth, G., H.-G. Kräusslich, K. Partin, and C. Carter. 1994. Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain. J. Virol. 68:240-250.
40. Zybarth, G., and C. Carter. 1995. Domains upstream of the protease (PR) in human immunodeficiency virus type 1 Gag-Pol influence PR autoprocessing. J. Virol. 69:3878-3884.